Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Elsevier"" wg kryterium: PB


Tytuł :
All-trans retinoic acid exerts selective anti-FLT3-ITD acute myeloid leukemia efficacy through downregulating Chk1 kinase.
Autorzy :
Wang W; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China; University of Science and Technology of China, Hefei, Anhui, 230036, PR China.
Jiang Z; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China; University of Science and Technology of China, Hefei, Anhui, 230036, PR China.
Wang L; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China; University of Science and Technology of China, Hefei, Anhui, 230036, PR China.
Wang A; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China.
Liu J; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China; University of Science and Technology of China, Hefei, Anhui, 230036, PR China.
Chen C; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China; University of Science and Technology of China, Hefei, Anhui, 230036, PR China.
Yu K; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China.
Zou F; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China.
Wang W; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China; Precision Medicine Research Laboratory of Anhui Province, Hefei, Anhui, 230088, PR China. Electronic address: .
Liu J; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China; Precision Medicine Research Laboratory of Anhui Province, Hefei, Anhui, 230088, PR China. Electronic address: .
Liu Q; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, PR China; University of Science and Technology of China, Hefei, Anhui, 230036, PR China; Precision Medicine Research Laboratory of Anhui Province, Hefei, Anhui, 230088, PR China; Institutes of Physical Science and Information Technology, Key Laboratory of Structure and Functional Regulation of Hybrid Materials, Ministry of Education, Anhui University, Hefei, Anhui, 230601, PR China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 130-138. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer.
Autorzy :
Barok M; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland; Laboratory of Molecular Oncology, University of Helsinki, Helsinki, FIN-00290, Finland. Electronic address: .
Le Joncour V; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland. Electronic address: .
Martins A; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland. Electronic address: .
Isola J; Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland. Electronic address: .
Salmikangas M; Laboratory of Molecular Oncology, University of Helsinki, Helsinki, FIN-00290, Finland. Electronic address: .
Laakkonen P; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland; Laboratory Animal Center, HiLIFE - Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland. Electronic address: .
Joensuu H; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland; Laboratory of Molecular Oncology, University of Helsinki, Helsinki, FIN-00290, Finland; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, FIN-00029, Finland. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 156-163. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
Autorzy :
Wang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Lu JH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Wang F; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Wang YN; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
He MM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Wu QN; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Lu YX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Yu HE; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Chen ZH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Zhao Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Liu J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Chen YX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Wang DS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Sheng H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Liu ZX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Zeng ZL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Xu RH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, China. Electronic address: .
Ju HQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 74-89. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
LncRNA RP11-361F15.2 promotes osteosarcoma tumorigenesis by inhibiting M2-Like polarization of tumor-associated macrophages of CPEB4.
Autorzy :
Yang D; Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Liu K; Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Fan L; Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Liang W; Department of Orthopaedics, Shaoxing People's Hospital, Shaoxing Hospital, Zhejiang University School of Medicine, Shaoxing, PR China. Electronic address: .
Xu T; Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Jiang W; Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Lu H; Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Jiang J; Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Wang C; Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Li G; Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Zhang X; The Institute of Intervention Vessel, Shanghai Tenth People's Hospital, Shanghai, PR China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 33-49. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.
Autorzy :
Tagliamonte M; Cancer Immunoregulation Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori IRCCS, 'Fondazione Pascale', Naples, Italy.
Mauriello A; Cancer Immunoregulation Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori IRCCS, 'Fondazione Pascale', Naples, Italy.
Cavalluzzo B; Cancer Immunoregulation Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori IRCCS, 'Fondazione Pascale', Naples, Italy.
Ragone C; Cancer Immunoregulation Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori IRCCS, 'Fondazione Pascale', Naples, Italy.
Manolio C; Cancer Immunoregulation Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori IRCCS, 'Fondazione Pascale', Naples, Italy.
Petrizzo A; Cancer Immunoregulation Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori IRCCS, 'Fondazione Pascale', Naples, Italy.
Buonaguro L; Cancer Immunoregulation Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori IRCCS, 'Fondazione Pascale', Naples, Italy. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 25-32. Date of Electronic Publication: 2019 Dec 23.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
ARID1A deficiency and immune checkpoint blockade therapy: From mechanisms to clinical application.
Autorzy :
Hu G; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: .
Tu W; Department of Rheumatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: .
Yang L; Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: .
Peng G; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .
Yang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 148-155. Date of Electronic Publication: 2020 Jan 03.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling.
Autorzy :
Zhou Z; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Xiangya Hospital, Central South University, Changsha, 40078, China; Cancer Research Institute, School of Basic Medicine Science, Central South University, Changsha, 410078, China.
Zhou Q; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Xiangya Hospital, Central South University, Changsha, 40078, China.
Wu X; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Xiangya Hospital, Central South University, Changsha, 40078, China; Cancer Research Institute, School of Basic Medicine Science, Central South University, Changsha, 410078, China.
Xu S; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Xiangya Hospital, Central South University, Changsha, 40078, China; Cancer Research Institute, School of Basic Medicine Science, Central South University, Changsha, 410078, China.
Hu X; Institute of Molecular Medicine and Oncology, College of Biology, Hunan University, Changsha, 410082, China.
Tao X; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Xiangya Hospital, Central South University, Changsha, 40078, China; Cancer Research Institute, School of Basic Medicine Science, Central South University, Changsha, 410078, China.
Li B; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410078, China.
Peng J; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410078, China.
Li D; Institute of Molecular Medicine and Oncology, College of Biology, Hunan University, Changsha, 410082, China.
Shen L; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Xiangya Hospital, Central South University, Changsha, 40078, China.
Cao Y; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Xiangya Hospital, Central South University, Changsha, 40078, China; Cancer Research Institute, School of Basic Medicine Science, Central South University, Changsha, 410078, China.
Yang L; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Xiangya Hospital, Central South University, Changsha, 40078, China; Cancer Research Institute, School of Basic Medicine Science, Central South University, Changsha, 410078, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 62-73. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities.
Autorzy :
Khan MA; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, USA; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Zubair H; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, USA; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Anand S; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, USA; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Srivastava SK; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, USA; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Singh S; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, USA; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA; Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL, 36688, USA.
Singh AP; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, USA; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA; Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL, 36688, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 176-185. Date of Electronic Publication: 2020 Jan 07.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer.
Autorzy :
Sheng R; Department of Obstetrics and Gynecology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Li X; Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 200092, China.
Wang Z; Department of Obstetrics and Gynecology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Wang X; Department of Obstetrics and Gynecology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 139-147. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Autorzy :
Ying H; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Ji L; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Xu Z; Department of Pathology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Fan X; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Tong Y; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Liu H; Biomedical Research Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Zhao J; Biomedical Research Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Cai X; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 13-24. Date of Electronic Publication: 2019 Dec 23.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.
Autorzy :
Yang Z; Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Chen J; Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Xie H; Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Liu T; Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Chen Y; Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Ma Z; Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Pei X; Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Yang W; Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Li L; Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 118-129. Date of Electronic Publication: 2019 Dec 13.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?
Autorzy :
Goh CY; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield Dublin, Dublin 4, Ireland; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield Dublin, Dublin 4, Ireland. Electronic address: .
Wyse C; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield Dublin, Dublin 4, Ireland; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield Dublin, Dublin 4, Ireland.
Ho M; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield Dublin, Dublin 4, Ireland; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield Dublin, Dublin 4, Ireland.
O'Beirne E; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield Dublin, Dublin 4, Ireland; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield Dublin, Dublin 4, Ireland.
Howard J; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield Dublin, Dublin 4, Ireland.
Lindsay S; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield Dublin, Dublin 4, Ireland.
Kelly P; UCD School of Veterinary Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield Dublin, Dublin 4, Ireland.
Higgins M; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield Dublin, Dublin 4, Ireland; Medical Oncology Department, Mater Misericordiae University Hospital (MMUH), Dublin, Dublin 7, Ireland.
McCann A; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield Dublin, Dublin 4, Ireland; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield Dublin, Dublin 4, Ireland.
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 90-97. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA.
Autorzy :
Ray J; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Canada.
Haughey C; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland, UK.
Hoey C; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Canada.
Jeon J; Ontario Institute for Cancer Research, Toronto, Canada.
Murphy R; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland, UK.
Dura-Perez L; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland, UK.
McCabe N; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland, UK.
Downes M; Department of Anatomic Pathology, University of Toronto, Canada.
Jain S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland, UK.
Boutros PC; Department of Medical Biophysics, University of Toronto, Canada; Ontario Institute for Cancer Research, Toronto, Canada.
Mills IG; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland, UK; Nuffield Department of Surgical Sciences, University of Oxford, UK.
Liu SK; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 107-117. Date of Electronic Publication: 2019 Dec 23.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].
Autorzy :
Bao L; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Yan Y; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Xu C; Changhai Hospital, Second Military Medical University, Shanghai, 200168, China.
Ji W; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Shen S; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Xu G; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Zeng Y; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Sun B; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Qian H; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Chen L; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Wu M; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China.
Chen J; Changhai Hospital, Second Military Medical University, Shanghai, 200168, China. Electronic address: .
Su C; Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai, 200438, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 198-199. Date of Electronic Publication: 2020 Jan 08.
Typ publikacji :
Published Erratum
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: PubMed not MEDLINE; MEDLINE
Tytuł :
TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
Autorzy :
Weiler SME; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Lutz T; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Bissinger M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Sticht C; Medical Faculty Mannheim, Medical Research Center, University of Heidelberg, Mannheim, Germany.
Knaub M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Gretz N; Medical Faculty Mannheim, Medical Research Center, University of Heidelberg, Mannheim, Germany.
Schirmacher P; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Breuhahn K; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 164-175. Date of Electronic Publication: 2020 Jan 03.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Proprotein convertases: Key players in inflammation-related malignancies and metastasis.
Autorzy :
Siegfried G; Univ. Bordeaux, 33000, Bordeaux, France; INSERM UMR1029, 33400, Pessac, France. Electronic address: .
Descarpentrie J; Univ. Bordeaux, 33000, Bordeaux, France; INSERM UMR1029, 33400, Pessac, France. Electronic address: .
Evrard S; Univ. Bordeaux, 33000, Bordeaux, France; Institut Bergonié, 33076, Bordeaux, France. Electronic address: .
Khatib AM; Univ. Bordeaux, 33000, Bordeaux, France; INSERM UMR1029, 33400, Pessac, France. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 50-61. Date of Electronic Publication: 2019 Dec 30.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Corrigendum to "Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis" [Canc. Lett. 461 (2019) 65-77].
Autorzy :
Tonucci FM; Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), Consejo de Investigaciones Científicas y Técnicas (CONICET), Rosario, Argentina.
Almada E; Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), Consejo de Investigaciones Científicas y Técnicas (CONICET), Rosario, Argentina.
Borini-Etichetti C; Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), Consejo de Investigaciones Científicas y Técnicas (CONICET), Rosario, Argentina.
Pariani A; Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), Consejo de Investigaciones Científicas y Técnicas (CONICET), Rosario, Argentina.
Hidalgo F; Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), Consejo de Investigaciones Científicas y Técnicas (CONICET), Rosario, Argentina.
Rico MJ; Instituto de Genética Experimental, Facultad de Ciencias Médicas - UNR, Rosario, Argentina.
Girardini J; Instituto de Inmunología Clínica y Experimental de Rosario, UNR - CONICET, Rosario, Argentina.
Favre C; Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), Consejo de Investigaciones Científicas y Técnicas (CONICET), Rosario, Argentina.
Goldenring JR; Epithelial Biology Center and Department of Cell & Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Menacho-Marquez M; Instituto de Investigaciones para el Descubrimiento de Fármacos-Laboratorio Max Plank de Rosario, UNR - CONICET, Rosario, Argentina.
Larocca MC; Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), Consejo de Investigaciones Científicas y Técnicas (CONICET), Rosario, Argentina. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 200-201. Date of Electronic Publication: 2020 Jan 10.
Typ publikacji :
Published Erratum
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: PubMed not MEDLINE; MEDLINE
Tytuł :
Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B.
Autorzy :
Xu J; Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, 210000, Nanjing, Jiangsu Province, PR China; Department of Hepatobiliary Surgery, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, 223001, Huai'an No.1, Jiangsu Province, PR China; Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, PR China. Electronic address: .
Lu Y; Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, 210000, Nanjing, Jiangsu Province, PR China; Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, PR China. Electronic address: .
Liu Q; Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, 210000, Nanjing, Jiangsu Province, PR China; Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, PR China. Electronic address: .
Xia A; Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, 210000, Nanjing, Jiangsu Province, PR China; Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, PR China. Electronic address: .
Zhao J; Department of Hepatobiliary Surgery, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, 223001, Huai'an No.1, Jiangsu Province, PR China. Electronic address: .
Xu X; Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, 210000, Nanjing, Jiangsu Province, PR China. Electronic address: .
Sun Q; Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, 210000, Nanjing, Jiangsu Province, PR China. Electronic address: .
Qi F; Department of Hepatobiliary Surgery, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, 223001, Huai'an No.1, Jiangsu Province, PR China. Electronic address: .
Sun B; Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, 210000, Nanjing, Jiangsu Province, PR China; Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, PR China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 1-12. Date of Electronic Publication: 2019 Dec 23.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
Autorzy :
Tam BY; Formerly Samumed, LLC, CA, USA.
Chiu K; Samumed, LLC, San Diego, CA, USA.
Chung H; Samumed, LLC, San Diego, CA, USA.
Bossard C; Samumed, LLC, San Diego, CA, USA.
Nguyen JD; Formerly Samumed, LLC, CA, USA.
Creger E; Samumed, LLC, San Diego, CA, USA.
Eastman BW; Samumed, LLC, San Diego, CA, USA.
Mak CC; Samumed, LLC, San Diego, CA, USA.
Ibanez M; Samumed, LLC, San Diego, CA, USA.
Ghias A; Samumed, LLC, San Diego, CA, USA.
Cahiwat J; Samumed, LLC, San Diego, CA, USA.
Do L; Samumed, LLC, San Diego, CA, USA.
Cho S; Samumed, LLC, San Diego, CA, USA.
Nguyen J; Samumed, LLC, San Diego, CA, USA.
Deshmukh V; Samumed, LLC, San Diego, CA, USA.
Stewart J; Samumed, LLC, San Diego, CA, USA.
Chen CW; Samumed, LLC, San Diego, CA, USA.
Barroga C; Samumed, LLC, San Diego, CA, USA.
Dellamary L; Formerly Samumed, LLC, CA, USA.
Kc SK; Samumed, LLC, San Diego, CA, USA.
Phalen TJ; Samumed, LLC, San Diego, CA, USA.
Hood J; Formerly Samumed, LLC, CA, USA.
Cha S; Samumed, LLC, San Diego, CA, USA.
Yazici Y; Samumed, LLC, San Diego, CA, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 186-197. Date of Electronic Publication: 2019 Sep 24.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
TRIM8 interacts with KIF11 and KIFC1 and controls bipolar spindle formation and chromosomal stability.
Autorzy :
Venuto S; Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy; PhD Program, Experimental and Regenerative Medicine, University of Foggia, Foggia, Italy. Electronic address: .
Monteonofrio L; Unit of Cellular Networks and Molecular Therapeutic Targets, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: .
Cozzolino F; CEINGE Advanced Biotechnology and Department of Chemical Sciences Federico II University, Napoli, Italy. Electronic address: .
Monti M; CEINGE Advanced Biotechnology and Department of Chemical Sciences Federico II University, Napoli, Italy. Electronic address: .
Appolloni I; University of Genova, Dept. of Experimental Medicine (DIMES), Genova, Italy. Electronic address: .
Mazza T; Unit of Bioinformatic, IRCCS Casa Sollievo Della Sofferenza, Mendel Institute, Rome, Italy. Electronic address: .
Canetti D; CEINGE Advanced Biotechnology and Department of Chemical Sciences Federico II University, Napoli, Italy. Electronic address: .
Giambra V; Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy. Electronic address: .
Panelli P; Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy. Electronic address: .
Fusco C; Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy. Electronic address: .
Squeo GM; Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy. Electronic address: .
Croce AI; Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy. Electronic address: .
Pucci P; CEINGE Advanced Biotechnology and Department of Chemical Sciences Federico II University, Napoli, Italy. Electronic address: .
Malatesta P; University of Genova, Dept. of Experimental Medicine (DIMES), Genova, Italy; Ospedale Policlinico San Martino, Genova, Italy. Electronic address: .
Soddu S; Unit of Cellular Networks and Molecular Therapeutic Targets, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: .
Merla G; Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy. Electronic address: .
Micale L; Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Mar 31; Vol. 473, pp. 98-106. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett. Subsets: In Process; MEDLINE
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies